What Does "Residual Disease" Mean?

Residual disease means cancer that remains after treatment. That treatment aimed to remove or destroy it. It most often comes up after surgery. There, it describes whether any tumor was left behind. It can also describe cancer that remains after chemotherapy or radiation. This is a different question from stage. Stage describes the cancer at diagnosis. Residual disease describes what is left after treatment happened.

After surgery, pathologists and surgeons often use a simple grading system called the R classification to describe what was left behind.

• R0 means no residual tumor. The margins are clear under the microscope. Margins are the edges of the tissue that was removed. This is the goal of most cancer surgery. It generally means the best outcome.
• R1 means microscopic residual disease. No tumor is visible to the naked eye. But cancer cells are still found at the edge of the removed tissue, when it is examined under a microscope. The surgery looked complete during the operation. The lab found otherwise.
• R2 means macroscopic residual disease. Visible tumor was left behind. This usually happens because removing all of it was not safe. The tumor often sits next to organs or vessels the surgeon must not damage.
• RX means the residual tumor status could not be assessed. This usually happens when the margins were not fully checked.

R0 resections are generally linked to the best outcomes and the lowest chance of recurrence. R1 and R2 both raise the risk that the cancer returns. R2 carries more concern than R1. Visible remaining tumor behaves differently than a few cells at a margin. This classification often changes what happens next. R1 or R2 findings frequently lead to additional treatment, such as radiation or more chemotherapy. That treatment aims at what surgery could not fully remove.

The term also applies after chemotherapy or radiation. This matters most for cancers treated with drugs before surgery, called neoadjuvant treatment. Here, residual disease describes how much cancer remains in the tissue removed afterward. Doctors compare that to how much was there before treatment started. Little or no residual disease after neoadjuvant treatment is generally a good sign. Substantial residual disease can prompt a change in the plan. Doctors sometimes add a different drug afterward, specifically because some cancer proved resistant to the first approach.

Residual disease describes what happened with this specific treatment. It does not by itself predict whether cancer will return elsewhere in the body. Some cancer cells can spread before surgery ever happens, in ways margins alone cannot catch. It also does not mean treatment failed entirely. R1 and R2 findings are common enough that entire additional treatment pathways exist specifically to address them.

• What was my residual disease classification — R0, R1, or R2 — and what does that mean for me specifically?
• Does this finding change my treatment plan, such as adding radiation or more chemotherapy?
• How does residual disease status affect my risk of recurrence?
• If I had neoadjuvant treatment, how much residual disease was found, and what does that suggest about how my cancer responded?

• Liposarcoma (surgical margin / R0-R1-R2 classification) — StatPearls, NCBI Bookshelf (NIH/NLM)
• National Cancer Institute — Tests and Procedures Used to Diagnose Cancer
• NCI Dictionary: residual disease